BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Deals

  Tekni-Plex acquires Dunn Industries, expands extruded medical tubing portfolio

  Tekni-Plex, Inc. has acquired Dunn Industries, Inc., a manufacturer of specialty extrusion tubing for medical device applications.

  April 4, 2018

   · 

  2 min read
• Business

  Lilly Confirms Date and Conference Call for First-Quarter 2018 Financial Results Announcement

  Eli Lilly and Company will announce its financial results for the first quarter of 2018 on Tuesday, April 24, 2018.

  April 4, 2018

   · 

  1 min read
• Lone Star Bio

  New Publication Highlights Significant Impact of DecisionDx-Melanoma Prognostic Test on Clinical Management of Patients with Melanoma

  Prospective, multicenter study recently published in SKIN The Journal of Cutaneous Medicine

  April 4, 2018

   · 

  5 min read
• Drug Development

  Sangamo Announces Publication In Molecular Therapy Of Preclinical Study Data From MPS II In Vivo Genome Editing Program

  Study provided proof of concept for development of SB-913 product candidate currently being evaluated in Phase 1/2 clinical trial.

  April 4, 2018

   · 

  7 min read
• Business

  PTC Therapeutics and CHDI Foundation Announce a Collaboration on a Small-Molecule Therapeutic for Huntington’s Disease

  The program is optimizing small-molecule compounds--identified using PTC’s splicing technology platform--that decrease the production of huntingtin protein.

  April 4, 2018

   · 

  5 min read
• Business

  Check-Cap Reports Fourth Quarter and Full Year 2017 Financial Results

  Announces the achievement of key validation milestones in C-Scan® system clinical and regulatory pathway

  April 4, 2018

   · 

  25 min read
• Bio NC

  Tenax Therapeutics Announces Results of Pre-IND Meeting with FDA for Phase 2 Study of Levosimendan in PH-HFpEF Patients

  FDA addressed the Company’s questions and provided guidance on its upcoming Phase 2 clinical trial in the use of levosimendan for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction

  April 4, 2018

   · 

  3 min read
• Genetown

  Siamab Therapeutics to Present New Data on its ST1 Antibody Therapeutic Program Targeting

  Tumor-Associated STn and STn+ Myeloid Derived Suppressor Cells at the AACR Annual Meeting 2018

  April 4, 2018

   · 

  4 min read
• FDA

  U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations

  FDA Priority Review Granted for U.S. New Drug Application

  April 4, 2018

   · 

  9 min read
• Business

  Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies

  Transaction provides potential for further development of novel mAbs while allowing Arsanis to continue to focus its resources on ongoing Phase 2 clinical trial of lead product candidate ASN100

  April 4, 2018

   · 

  6 min read